Effect of Raxibacumab on Immunogenicity of Anthrax Vaccine Adsorbed

Clinical trial NCT02339155 · COMPLETED

Trial details

NCT number: NCT02339155
Sponsor: Emergent BioSolutions
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Infections, Bacterial

Start date: 2015-02-24
Primary completion: 2017-01-03
Enrollment: 573

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.